A genetic variant of 5-hydroxytryptamine receptor 3C (HTR3C): A novel link to chemotherapy-induced side effects.

Tami Rubinek, Dorit Pud, Gil Har-Zahav, Zvi Symon, Yael Laitman, Ido Wolf

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageAmerican English
Article number9630
Pages (from-to)1
JournalJournal of Clinical Oncology
Issue number15 Supplement
StatePublished - 2013
EventASCO Annual Meeting Proceedings: PATIENT AND SURVIVOR CARE -
Duration: 31 May 20134 Jun 2013

Cite this